Navigation Links
San Diego's Original Biotech Company Celebrates 30th Anniversary With Reunion

Hybritech Alumni Launched the World's 3rd Largest Biotech Cluster By

Developing more than 175 Local Companies

SAN DIEGO, Sept. 9 /PRNewswire/ -- The Hybritech Reunion Committee today announced the 30th Anniversary Reunion for Hybritech employees will take place on Saturday, September 13th, 2008 at the headquarters of AMN Healthcare in San Diego.

In September 1978 Hybritech, San Diego's "Granddaddy" biotech company, began operations in temporary trailers located in the parking lot of the La Jolla Cancer Research Foundation (now the renowned Burnham Institute). The company quickly produced the world's first commercially manufactured monoclonal antibody product, and soon thereafter, a series of diagnostic kits for allergy, pregnancy, anemia and certain forms of cancer. The company was also instrumental in the earliest investigations of in vivo and therapeutic applications of monoclonal antibodies for the diagnosis and treatment of cancer.

By 1985, Hybritech had developed its "Prostate Specific Antigen (PSA)" product, the first monoclonal antibody test for prostate cancer. The blood test soon became the standard method for physicians to diagnose and monitor prostate cancer patients, the second biggest cancer killer among American men.

In 1986, the pharmaceutical company, Eli Lilly paid $450 million in cash and warrants to buy Hybritech -- at that point the largest M&A in San Diego history. The company's early success -- and the visibility it created among its founders and employees -- spurred other academic scientists and entrepreneurs to form dozens of additional life sciences companies in San Diego.

Hybritech's original founders and employees have gone on to found more than 175 of the several hundred life science companies now located in San Diego county -- and comprising the San Diego life sciences "technology cluster".

"This event is a milestone celebration of all the tremendous things that came from the genesis of this small company 30 years ago. Who would have foreseen how significant the impact of one company could be on our community's economy and its reputation as a leading area of biotech research and scientific development? I am very proud to have led this brilliant, dedicated and innovative group of individuals," said Ted Greene, chief executive of Hybritech until the Lilly acquisition.

"There are several hundred Hybritech alumni who continue to live and work here in San Diego who plan to attend the reunion. We also have former employees planning to attend who currently live across the United States and in Europe -- and who are returning to San Diego for the event. These Hybritech alumni rank among the earliest founders of San Diego's now vibrant biotech and life sciences 'technology cluster'. Many people, even former employees, are surprised to learn that the Hybritech success has become a point of study among academic and governmental investigators who want to understand how 'technology clusters' are successfully created and sustained," said Cole Owen, a member of the Hybritech Reunion Committee.

The Hybritech 30th Anniversary Reunion (for former Hybritech employees only) will be held at the AMN Healthcare facility in San Diego, on Saturday, September 13, 2008, beginning at 3 PM. The host for the Reunion is AMN's President and CEO, Susan Nowakowski, herself a Hybritech alumnus.

Further registration information is available online at for former Hybritech employees and media.

The Hybritech Reunion is a non profit corporation dedicated to preserving the legacy of Hybritech.

SOURCE Hybritech Reunion Committee
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
2. Three Expert Opinion Journals now Publishing Original Research
3. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
4. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
5. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
6. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
7. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
8. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
9. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
10. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
11. Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
Post Your Comments:
(Date:11/25/2015)... 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... CEO of Neurocrine Biosciences, will be presenting at the ... New York . .   ... 5 minutes prior to the presentation to download or ... will be available on the website approximately one hour ...
(Date:11/25/2015)... 2015 Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... fireside chat discussion at the Piper Jaffray 27th Annual ... The discussion is scheduled for Wednesday, December 2, at ... A replay will be available for 14 days after ... Julie NormartVP, Corporate Communications and Business Development , BrewLife(858) ...
(Date:11/24/2015)... 2015  Asia-Pacific (APAC) holds the third-largest share ... The trend of outsourcing to low-cost locations is ... volume share for the region in the short ... in the CRO industry will improve. ... ), finds that the market earned revenues ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
Breaking Biology Technology:
(Date:11/20/2015)... OXFORD, Connecticut , November 20, 2015 ... biometric authentication company focused on the growing mobile commerce ... its CEO, Gino Pereira , was recently interviewed ... The interview will air on this weekend on ... Bloomberg Latin America . --> NXTD ) ...
(Date:11/19/2015)... 19, 2015  Although some 350 companies are actively ... a few companies, according to Kalorama Information. These include Roche ... the market share of the 6.1 billion-dollar molecular testing ... Market for Molecular Diagnostic s .    ... still controlled by one company and only a handful ...
(Date:11/18/2015)... --> --> ... report titled  Gesture Recognition Market - Global Industry Analysis, ... to the report, the global gesture recognition market was valued at ... US$29.1 bn by 2021, at a CAGR of 20.3% ... dominated the global gesture recognition market in ...
Breaking Biology News(10 mins):